HOUSTON and MINNEAPOLIS, Aug. 3, 2015 /PRNewswire/ -- Boston Scientific (NYSE: BSX) has become a significant shareholder and will become the exclusive worldwide sales and marketing representative for Preventice Solutions for cardiology-related diagnostic and monitoring offerings.

Preventice Solutions: a strategic combination of eCardio and Preventice

"This agreement marks an important strategic milestone for Preventice Solutions," said Jon Otterstatter, President and Chief Global Strategy Officer, co CEO, Preventice Solutions.  "We are thrilled to partner with Boston Scientific and collaborate on additional areas of mutual commercial and strategic interest."

"By partnering with Boston Scientific, we will expand our service capability and build a foundation for a future in the management of remote patient care," said John Untereker, Executive Vice President and Chief Operating Officer, co CEO, Preventice Solutions. 

The market for cardiac monitoring solutions is greater than $1B. Technologies include wearable monitors that detect and record heart rhythms such as Holter, cardiac event monitors (CEM), mobile cardiac telemetry (MCT) as well as implantable or insertable cardiac monitors. These products are often surrounded by monitoring services including data transmission, surveillance, reporting, interpretation, and integration into a provider's workflow.  Preventice Solutions' portfolio includes PatientCare Platform and the BodyGuardian® range of products i.e. BodyGuardian® Heart, BodyGuardian® Verité and BodyGuardian® Holter.

About Preventice Solutions
Preventice Solutions, a leading developer of mobile health solutions and services, was created by a strategic combination of Preventice Services, formerly eCardio Diagnostics® and Preventice Technologies, formerly Preventice® in 2014.Together, we are designing the industry's superior customer service experience. Using insights to create revolutionary monitoring technologies and services that connect patients and caregivers, this tech-enabled, service-based approach can ultimately reduce the cost of care and improve health outcomes.  To learn more about Preventice Solutions, visit www.preventicesolutions.com

Logo - http://photos.prnewswire.com/prnh/20150510/214933LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/boston-scientific-announces-equity-investment-and-sales-cooperation-agreement-with-preventice-solutions-300122816.html

SOURCE Preventice Solutions

Copyright 2015 PR Newswire

Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Boston Scientific Charts.
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Boston Scientific Charts.